Rapid Antibody Test
The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to U.S. laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), to perform moderate and high complexity tests. The COVID-19 rapid antibody test only requires 15 minutes to check if you’ve been exposed to Coronavirus and have developed immunity. The test is conducted with patients who are experiencing symptoms of flu, cough and fever to get a more accurate result of whether it is the virus causing it or just a viral.
Conduction of our tests in detail
Collection and Handling of Samples
The handling of specimen collected while the Antigen test is conducted is the most important part to get accurate results. Delays from sample collection to testing should be minimized. Improper specimen collection may cause some swabs to have limited amounts of viral genetic or antigenic material for detection. Inadequate quality assurance procedures could result in cross contamination of the sample, which could cause inaccurate test results.
- Collect blood/serum/plasma sample.
- Add blood/serum/plasma sample to sample well.
- Place 2-3 drops of buffer in the machine.
- Read results after 10 minutes and no more than 15 minutes.
Machines used for conducting tests
The machine used for conducting tests is the BD Veritor™ System, which is slightly larger than a cell phone. It is currently in use at more than 25,000 hospitals, clinician offices, urgent care centers and retail pharmacies in all 50 U.S. states. Its one-button functionality, workflow flexibility, and ease-of-use make it an ideal solution for settings without laboratory personnel. It also offers customers real-time reporting capabilities through the BD Synapsys™ informatics solution providing them with the ability to easily report data for disease monitoring and surveillance purposes.